Accent Therapeutics
5 known investors
Accent is a drug discovery company developing small molecule therapeutics for cancer by targeting cellular dependencies arising from genomic and chromosomal instability. It focuses on oncology programs aimed at patient populations with unmet medical need.
BiotechLongevity
Investors · 5
In the news
Frequently asked questions
- What does Accent Therapeutics do?
- Accent is a drug discovery company developing small molecule therapeutics for cancer by targeting cellular dependencies arising from genomic and chromosomal instability. It focuses on oncology programs aimed at patient populations with unmet medical need.
- Who are Accent Therapeutics's investors?
- Accent Therapeutics's investors include Atlas Venture, Droia Ventures, EcoR1 Capital, GV (Google Ventures), The Column Group.